Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 24% ± 10% | |
GABAergic neuron | 5 studies | 25% ± 9% | |
epithelial cell | 4 studies | 29% ± 12% | |
glutamatergic neuron | 4 studies | 36% ± 13% | |
neuron | 4 studies | 32% ± 14% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 3% | |
non-classical monocyte | 3 studies | 21% ± 3% | |
connective tissue cell | 3 studies | 21% ± 5% | |
fibroblast | 3 studies | 19% ± 2% | |
interneuron | 3 studies | 26% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 25% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2430.27 | 180 / 180 | 100% | 59.05 | 430 / 430 |
prostate | 100% | 2753.05 | 245 / 245 | 100% | 50.66 | 502 / 502 |
brain | 100% | 2219.62 | 2641 / 2642 | 100% | 78.30 | 705 / 705 |
thymus | 100% | 3044.32 | 653 / 653 | 100% | 63.68 | 604 / 605 |
uterus | 100% | 2648.38 | 170 / 170 | 100% | 44.30 | 458 / 459 |
kidney | 100% | 1975.13 | 89 / 89 | 100% | 39.07 | 897 / 901 |
breast | 100% | 2154.71 | 458 / 459 | 100% | 48.69 | 1114 / 1118 |
skin | 100% | 1997.84 | 1808 / 1809 | 99% | 35.76 | 468 / 472 |
bladder | 100% | 2335.33 | 21 / 21 | 98% | 35.86 | 496 / 504 |
pancreas | 99% | 876.30 | 324 / 328 | 99% | 37.32 | 177 / 178 |
adrenal gland | 100% | 1986.93 | 258 / 258 | 98% | 31.68 | 225 / 230 |
lung | 99% | 1560.04 | 575 / 578 | 98% | 33.76 | 1133 / 1155 |
intestine | 100% | 2342.54 | 966 / 966 | 97% | 23.11 | 512 / 527 |
liver | 98% | 998.66 | 222 / 226 | 99% | 25.16 | 400 / 406 |
stomach | 100% | 1668.96 | 359 / 359 | 93% | 20.07 | 266 / 286 |
esophagus | 100% | 2025.55 | 1445 / 1445 | 86% | 14.36 | 157 / 183 |
blood vessel | 100% | 2124.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.02 | 29 / 29 |
spleen | 100% | 3065.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.22 | 1 / 1 |
adipose | 100% | 1663.81 | 1200 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1034.87 | 849 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 845.39 | 778 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 25.13 | 77 / 80 |
peripheral blood | 91% | 1185.99 | 848 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902749 | Biological process | regulation of cell cycle G2/M phase transition |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0001558 | Biological process | regulation of cell growth |
GO_0006338 | Biological process | chromatin remodeling |
GO_1902164 | Biological process | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0140889 | Biological process | DNA replication-dependent chromatin disassembly |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2000278 | Biological process | regulation of DNA biosynthetic process |
GO_0006915 | Biological process | apoptotic process |
GO_0006473 | Biological process | protein acetylation |
GO_0045926 | Biological process | negative regulation of growth |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0000123 | Cellular component | histone acetyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0043997 | Molecular function | histone H4K12 acetyltransferase activity |
GO_0036408 | Molecular function | histone H3K14 acetyltransferase activity |
GO_0046972 | Molecular function | histone H4K16 acetyltransferase activity |
GO_0043996 | Molecular function | histone H4K8 acetyltransferase activity |
GO_0043995 | Molecular function | histone H4K5 acetyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ING4 |
Protein name | Inhibitor of growth family member 4 variant deltaEx6B (cDNA FLJ53613, highly similar to Inhibitor of growth protein 4) Inhibitor of growth family member 4 Inhibitor of growth protein 4 (p29ING4) |
Synonyms | My036 |
Description | FUNCTION: Component of HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), and have reduced activity toward histone H4 . Through chromatin acetylation it may function in DNA replication . May inhibit tumor progression by modulating the transcriptional output of signaling pathways which regulate cell proliferation . Can suppress brain tumor angiogenesis through transcriptional repression of RELA/NFKB3 target genes when complexed with RELA . May also specifically suppress loss of contact inhibition elicited by activated oncogenes such as MYC . Represses hypoxia inducible factor's (HIF) activity by interacting with HIF prolyl hydroxylase 2 (EGLN1) . Can enhance apoptosis induced by serum starvation in mammary epithelial cell line HC11 (By similarity). . |
Accessions | ENST00000467678.5 R4GNG1 ENST00000482489.5 ENST00000444704.5 [Q9UNL4-3] E9PJ14 E9PNE3 ENST00000493873.1 ENST00000619641.4 ENST00000341550.9 [Q9UNL4-2] ENST00000488381.5 ENST00000446105.6 [Q9UNL4-4] Q9UNL4 ENST00000423703.6 [Q9UNL4-8] A4KYM5 ENST00000469749.5 ENST00000412586.6 [Q9UNL4-5] A4KYM7 H0YEH7 ENST00000479301.5 ENST00000396807.8 [Q9UNL4-1] |